Doctor profile · Federal record

Dr. Kate Mimken, NP-C

Family Nurse Practitioner (CMS: Nurse Practitioner) · Denver, CO

  • NPI 1912426578
  • Accepts Medicare
  • 9 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1721 E 19Th Ave
Denver, CO 802181251
(303) 754-4800
Mailing address
2347 N High St
Denver, CO 802055561

Credentials & registration

NPPES · NUCC
NPI registered
September 2017 — 9 yrs on file
Year of graduation
2017 — 9 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State license (1)
Colorado #APN.09933331-NP

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1912426578. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
428
Distinct HCPCS
5
Medicare allowed
$55,945
HCPCS Description Services Patients Avg allowed
99215 Established patient office or other outpatient visit, 40-54 minutes 216 119 $152
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 114 43 $100
99214 Established patient office or other outpatient visit, 30-39 minutes 70 58 $110
38222 Biopsy and aspiration of bone marrow sample for diagnosis 16 15 $146
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 12 11 $138

In context: peer comparison

Among 67 peers in this city , average services per provider: 71. This provider delivers 6.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$583
Transactions
21
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
GENZYME CORPORATION 2 $177.96
ABBVIE INC. 4 $80.04
Celgene Corporation 3 $75.44
Legend Biotech USA Inc. 1 $37.07
SOBI, INC 1 $23.41
BeiGene USA, Inc. 1 $23.26
Adaptive Biotechnologies Corporation 1 $22.23
Daiichi Sankyo Inc. 1 $21.71
PFIZER INC. 1 $19.71
Astellas Pharma US Inc 1 $18.97
Takeda Pharmaceuticals U.S.A., Inc. 1 $18.08
Genmab U.S., Inc. 1 $17.42
Janssen Biotech, Inc. 1 $17.22
Incyte Corporation 1 $16.61
Genentech USA, Inc. 1 $14.10

By nature of payment

Food and Beverage
$583

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
532
Patients
101
Total drug cost
$2,948,716
Drug Type Claims Patients Total cost
Lenalidomide Generic 85 0 $1,066,990
Acyclovir Generic 78 32 $2,411
Pomalyst (Pomalidomide) Brand 48 0 $1,006,473
Valacyclovir (Valacyclovir Hcl) Brand 46 11 $2,745
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 37 0 $244
Ondansetron Odt (Ondansetron) Brand 31 22 $523
Revlimid (Lenalidomide) Brand 30 0 $567,894
Prednisone Generic 29 13 $154
Gabapentin Generic 23 0 $87
Xarelto (Rivaroxaban) Brand 23 0 $31,376

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Kate Mimken's medical specialty?
Dr. Kate Mimken practices Family Nurse Practitioner in Denver, CO.
Where does Dr. Kate Mimken practice?
Dr. Kate Mimken practices at 1721 E 19Th Ave, Denver, CO 802181251. Office phone: 3037544800.
What is Dr. Kate Mimken's NPI?
Dr. Kate Mimken's National Provider Identifier (NPI) is 1912426578, issued by NPPES.
Does Dr. Kate Mimken accept Medicare assignment?
Yes. Dr. Kate Mimken accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kate Mimken commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.